Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Top Cited Papers
- 1 November 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 124 (18), 1973-1981
- https://doi.org/10.1161/circulationaha.110.015008
Abstract
Background— Chronic thromboembolic pulmonary hypertension (CTEPH) is often a sequel of venous thromboembolism with fatal natural history; however, many cases can be cured by pulmonary endarterectomy. The clinical characteristics and current management of patients enrolled in an international CTEPH registry was investigated. Methods and Results— The international registry included 679 newly diagnosed (≤6 months) consecutive patients with CTEPH, from February 2007 until January 2009. Diagnosis was confirmed by right heart catheterization, ventilation-perfusion lung scintigraphy, computerized tomography, and/or pulmonary angiography. At diagnosis, a median of 14.1 months had passed since first symptoms; 427 patients (62.9%) were considered operable, 247 (36.4%) nonoperable, and 5 (0.7%) had no operability data; 386 patients (56.8%, ranging from 12.0%– 60.9% across countries) underwent surgery. Operable patients did not differ from nonoperable patients relative to symptoms, New York Heart Association class, and hemodynamics. A history of acute pulmonary embolism was reported for 74.8% of patients (77.5% operable, 70.0% nonoperable). Associated conditions included thrombophilic disorder in 31.9% (37.1% operable, 23.5% nonoperable) and splenectomy in 3.4% of patients (1.9% operable, 5.7% nonoperable). At the time of CTEPH diagnosis, 37.7% of patients initiated at least 1 pulmonary arterial hypertension–targeted therapy (28.3% operable, 53.8% nonoperable). Pulmonary endarterectomy was performed with a 4.7% documented mortality rate. Conclusions— Despite similarities in clinical presentation, operable and nonoperable CTEPH patients may have distinct associated medical conditions. Operability rates vary considerably across countries, and a substantial number of patients (operable and nonoperable) receive off-label pulmonary arterial hypertension–targeted treatments.This publication has 36 references indexed in Scilit:
- Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registryThe Journal of Thoracic and Cardiovascular Surgery, 2011
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary HypertensionCirculation, 2009
- Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertensionEuropean Respiratory Journal, 2008
- Long-Term Recovery of Exercise Ability After Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary HypertensionThe Annals of Thoracic Surgery, 2006
- Controversies, Uncertainties and Future Research on the Treatment of Chronic Thromboembolic Pulmonary HypertensionProceedings of the American Thoracic Society, 2006
- Assessment of Operability in Chronic Thromboembolic Pulmonary HypertensionProceedings of the American Thoracic Society, 2006
- Incidence of Chronic Thromboembolic Pulmonary Hypertension After a First Episode of Pulmonary EmbolismSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2006
- Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertensionThrombosis and Haemostasis, 2005
- High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertensionThrombosis and Haemostasis, 2003
- Antiphospholipid antibodies and thrombosisThe Lancet, 1999